Apoa5(ab) (AA 20-363) anticorps
-
- Antigène
- Apoa5(ab)
- Épitope
- AA 20-363
- Reactivité
- Humain
- Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Inconjugué
- Application
- ELISA, Western Blotting (WB)
- Purification
- purified
- Immunogène
- Purified recombinant fragment of human APOA5 (AA: 20-363) expressed in E. coli.
- Clone
- 1G5G9(c)
- Isotype
- IgG1
-
-
- Indications d'application
- ELISA: 1:10000, WB: 1:500 - 1:2000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Purified antibody in PBS containing 0.03 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- 4°C, -20°C for long term storage
-
- Antigène
- Apoa5(ab)
- Autre désignation
- Apoa5 (ab)
- Sujet
-
Description: Apolipoprotein A5 (ApoA5) is fast gaining attention as a key regulator of serum triglyceride concentrations. An ApoA5 mouse knock-out model produced an approximately four fold increase in serum triglycerides, whereas a knock-in model with human ApoA5 produced 50-70 % lower , concentrations of mouse serum triglycerides. In addition, peroxisome proliferator-activated receptor-_ agonists, which are used clinically to lower serum triglyceride concentrations, cause increased ApoA5 mRNA expression. Recently, it was demonstrated that ApoA5 is present in human serum detected by polyclonal antibodies against both the NH2 and COOH termini, although at much lower concentration than other apolipoproteins.
Aliases: RAP3, APOAV, APOA-V
- ID gène
- 116519
- HGNC
- 116519
-